Litcius/Paper detail

The COVID-19 Cytokine Storm; What We Know So Far

Dina Ragab, Haitham Salah Eldin, Mohamed Taeimah, Rasha Khattab, Ramy Salem

2020Frontiers in Immunology1,698 citationsDOIOpen Access PDF

Abstract

COVID-19 is a rapidly spreading global threat that has been declared as a pandemic by the WHO. COVID-19 is transmitted via droplets or direct contact and infects the respiratory tract resulting in pneumonia in most of the cases and acute respiratory distress syndrome (ARDS) in about 15 % of the cases. Mortality in COVID-19 patients has been linked to the presence of the so-called "cytokine storm" induced by the virus. Excessive production of proinflammatory cytokines leads to ARDS aggravation and widespread tissue damage resulting in multi-organ failure and death. Targeting cytokines during the management of COVID-19 patients could improve survival rates and reduce mortality.

Topics & Concepts

ARDSCytokine stormProinflammatory cytokineCoronavirus disease 2019 (COVID-19)PneumoniaMedicinePandemicIntensive care medicineCytokineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Acute respiratory distressImmunologyLungInternal medicineInflammationInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19COVID-19 and healthcare impacts
The COVID-19 Cytokine Storm; What We Know So Far | Litcius